Katharina Aigner-Radakovics

2PUBLICATIONS
7CO-AUTHORS
Haematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 19, 2024
LAG-3-An incompletely understood target in cancer therapy.

Judith Leitner, Katharina Aigner-Radakovics, Peter Steinberger

|Oct 03, 2023
The ligand-dependent suppression of TCR signaling by the immune checkpoint receptor LAG3 depends on the cytoplasmic RRFSALE motif.

Katharina Aigner-Radakovics, Annika De Sousa Linhares, Benjamin Salzer

Pageof 1